RETATRUTIDE

Retatrutide has been investigated in research settings focused on multi-receptor metabolic signalling, specifically targeting GLP-1, GIP, and glucagon pathways. Presented as a high-purity lyophilised compound, it is intended exclusively for laboratory-based investigation.

Purity: 99%
Appearance: White lyophilised powder
Format: Sterile sealed vial
Quantity: 10mg

Refrigeration at 2–8°C is suitable for short-term handling. Avoid repeated freeze-thaw cycles.

This product is intended for laboratory research purposes only. Not for human or veterinary use. Not for therapeutic or diagnostic applications.